View in EDS HTML Full Text PDF Full Text

Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer.
Authors: Mogenet, Alice1 (AUTHOR), Finetti, Pascal2 (AUTHOR), Denicolai, Emilie2 (AUTHOR), Greillier, Laurent1 (AUTHOR), Boudou-Rouquette, Pascaline3 (AUTHOR), Goldwasser, François3 (AUTHOR), Lumet, Gwenael2 (AUTHOR), Ceccarelli, Michele4 (AUTHOR), Birnbaum, Daniel2 (AUTHOR), Bedognetti, Davide5,6 (AUTHOR), Mamessier, Emilie2 (AUTHOR), Barlesi, Fabrice7 (AUTHOR), Bertucci, François2,8 (AUTHOR) bertuccif@ipc.unicancer.fr, Tomasini, Pascale1,2 (AUTHOR)
Source: Journal of Translational Medicine. 9/19/2023, Vol. 21 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14795876
DOI:10.1186/s12967-023-04463-2